GUN (Gunz) fluctuates 53.5% in 24 hours: surge in trading volume driven by community pump speculation
Bitget Pulse2026/04/20 22:03Volatility Brief
In the past 24 hours, the price of GUN hit a low of $0.01914 and a high of $0.02938. It is currently quoted at $0.02551, with a price fluctuation of 53.5%. Trading volume has significantly expanded, reaching $164 million to $202 million, marking a notable increase of 517% compared to before.
Analysis of the Cause of Abnormal Movement
- Driven by trading data: Open Interest (OI) surged by 109%, trading volume soared by 517%, and DEX (such as Avalanche LFJ) trading was active, driving a vertical price increase.
- Sudden community discussion: Multiple posts on the X platform recorded the pump initiation about 3 hours ago, with prices rising consecutively between 15.2% and 46%, without any official announcement or confirmed on-chain whale transactions.
Market Views and Outlook
The mainstream sentiment in the community is bullish, with traders recognizing an upward short-term structure. However, most warn that a 1h RSI of 88 and a funding rate of 0.16% indicate crowded longs, which could easily result in a pullback to the $0.018-$0.019 support region. If $0.01823 holds and a reversal is confirmed, it may continue towards $0.022-$0.024; otherwise, a retest of $0.016 could occur.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Marvell Technology (MRVL.US) plummets after earnings: Beating forecasts is not enough—Wall Street thinks Google (GOOGL.US) orders are recognized too slowly
Although Marvell Technology's latest financial report and future revenue guidance both superficially exceeded market expectations, its stock price still plummeted in pre-market trading on Friday.

Gold prices could soar to $12,000 if US national debt keeps rising, says strategist
PURR stock hits record $14.15 as Hyperliquid revenue tops $718 million
From Lowering Blood Sugar and Weight Loss to Cardiovascular Protection! Mounjaro Achieves "Cardiometabolic Leap," Lilly (LLY.US) Opens GLP-1's Second Growth Curve
Eli Lilly's diabetes drug Mounjaro has received approval in the United States for reducing the risk of serious cardiovascular disease. The U.S. Food and Drug Administration has approved Mounjaro for lowering cardiovascular risk in adults with type 2 diabetes who have established heart disease.
